Advanced Tools Provide Better Solutions for Critical Aspect of Biologics Development Scaling up biologics production from the bench to clinical and commercial scale is a central consideration of ...

See how BioDlink’s digital-intelligence platform is driving three major improvements in lyophilization workflows.

Before the advent of biologics, commercialization of a therapeutic relied on successfully scaling up to meet market demand. This scaling-up strategy expanded biomanufacturing capacity by upsizing the ...

Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...

Transferring a biologic candidate from the research and development phase to commercial production usually requires increasing the working volume of the upstream bioprocess. During scale-up, process ...

For the first time in history, a pathway for ALD-enhanced materials to be rapidly developed and transitioned from lab-scale to commercial production is available for nearly any application. Until ...